Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals.
Bacher
Ulrike
U
Zander
Axel R
AR
D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects* / Q000494:pharmacology; D019337:Hematologic Neoplasms / Q000209:etiology; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D036102:Peripheral Blood Stem Cell Transplantation; D011994:Recombinant Proteins; D012306:Risk; D013997:Time Factors; D014019:Tissue Donors
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim